FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File Photo Post navigation Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows